Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
323.28%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 5.99Close
$ 1.15 - $ 6.67 52-Week Range
Ticker Information
Ticker
PRMECompany Name
PRIME MEDICINE INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPRIME MEDICINE INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PRME - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 16.04M | 323.28% | $ 4.96M |
| 3/31/2025 | $ 17.93M | 466.28% | $ 3.85M |
| 12/31/2024 | $ 18.48M | 619.61% | $ 2.98M |
| 9/30/2024 | $ 19.15M | 2394.13% | $ 800K |
| 6/30/2024 | $ 19.74M | 3339.59% | $ 591K |
| 3/31/2024 | $ 18.22M | 3083.08% | $ 591K |
| 12/31/2023 | $ 17.44M | 0% | $ 0 |
| 9/30/2023 | $ 16.51M | 0% | $ 0 |
| 6/30/2023 | $ 15.54M | 0% | $ 0 |
| 12/31/2022 | $ 12.01M | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- PRIME MEDICINE INC's latest trailing twelve months (TTM) DepAmor % stands at 0%.
- Over the past 5 years, PRIME MEDICINE INC's average DepAmor % has been 1704.33%.
- The median DepAmor % for PRIME MEDICINE INC during this period was 1506.87%
- PRIME MEDICINE INC reached its highest DepAmor % over the past 5 years at 3339.59%.
- The lowest DepAmor % recorded by PRIME MEDICINE INC in the same timeframe 323.28%
PRIME MEDICINE INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for PRIME MEDICINE INC is calculated as follows: DepAmor [ $ 7.93M ] / Revenues [ $ 0 ]
(=) DepAmor % [ 0% ] PRME - Depreciation and Amortization Margin, Last 5 years
323.28%
Minimum
Jun 30, 2025
3339.59%
Maximum
Jun 30, 2024
1704.33%
Average
1506.87%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.84% with a standard deviation of 5.11%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.51% |
| average | 5.84% |
| median | 4.21% |
| std | 5.11% |